Methamphetamine is a powerful synthetic stimulant that speeds up the central nervous system, producing intense bursts of energy and euphoria. It is classified as a Schedule II controlled substance in the United States, meaning it carries a high potential for abuse but does have a narrow, FDA-approved medical use. Most people encounter it as an illegal street drug, commonly called meth, crystal, ice, or crank, though a prescription form (Desoxyn) exists for treating ADHD in children age six and older.
How Methamphetamine Affects the Brain
Methamphetamine works by flooding the brain with dopamine, the chemical messenger tied to pleasure, motivation, and reward. Normally, nerve cells release dopamine in small, controlled amounts and then reabsorb it. Meth disrupts that cycle in several ways at once: it enters nerve cells through dopamine transporters, forces dopamine to flow back out of the cell in large quantities, and blocks the recycling process that would normally clear dopamine from the space between neurons. It also interferes with how dopamine is stored inside nerve cells, essentially dumping the reserve supply into active circulation.
The result is a surge of dopamine far beyond anything the brain produces in response to natural rewards like food, exercise, or sex. Lab studies have found that methamphetamine releases roughly five times more dopamine than regular amphetamine at comparable doses. This outsized flood is what drives the intense high, but it is also what makes the drug so damaging and so difficult to stop using.
Methamphetamine vs. Amphetamine
Methamphetamine and amphetamine are closely related, but they are not the same drug. The key structural difference is a single methyl group attached to the amphetamine molecule, which makes methamphetamine more fat-soluble. That small change lets it cross into the brain faster and in greater concentrations. At the cellular level, methamphetamine triggers stronger electrical currents in dopamine-transporting neurons and pushes out significantly more dopamine than amphetamine does at the same dose. The National Institute on Drug Abuse describes methamphetamine as a more potent stimulant with longer-lasting effects. Prescription amphetamines (like those used for ADHD) are carefully dosed and formulated to release slowly, which is a very different experience from illicit meth.
Immediate Effects on the Body
Within minutes of smoking, injecting, or snorting meth, users typically feel a rush of energy and confidence. Heart rate and blood pressure climb. Body temperature rises. Appetite drops sharply. People often feel more alert, talkative, and physically restless. Depending on how it is taken, the high can last anywhere from 8 to 24 hours, far longer than cocaine or most other stimulants.
At higher doses or during binges (sometimes called “tweaking”), users may go days without sleeping. As the high fades, a crash follows, bringing extreme fatigue, depression, and intense cravings.
Long-Term Brain Damage
Chronic meth use physically changes the brain. Imaging studies show that long-term users have reduced levels of dopamine transporters across multiple brain regions, including areas involved in decision-making, impulse control, and emotional regulation. The drug also damages serotonin pathways, which help regulate mood and sleep. Structural MRI scans reveal measurable losses of grey matter in the frontal cortex, the hippocampus (critical for memory), and the limbic system (which processes emotions).
These changes translate into real cognitive problems. People who use meth heavily often develop deficits in attention, working memory, and executive function, the ability to plan, organize, and follow through on tasks. Some of this damage can partially reverse after months or years of abstinence, but recovery is slow and not always complete.
Methamphetamine-Induced Psychosis
Up to 40% of meth users experience some form of transient psychotic symptoms during intoxication. These brief episodes, such as mild paranoia or fleeting hallucinations, are considered part of the drug’s expected effects and do not necessarily indicate a psychiatric disorder. However, some users develop a full psychotic episode that goes well beyond typical intoxication.
Methamphetamine-induced psychosis most commonly involves paranoid delusions, auditory hallucinations, and tactile hallucinations (the sensation of bugs crawling under the skin, sometimes called “meth mites”). Ideas of reference, where a person believes random events are directed at them personally, are also common. Violent behavior is frequently linked to paranoid delusions during these episodes. A diagnosis of substance-induced psychotic disorder applies when hallucinations or delusions develop during or soon after meth use and clearly exceed what intoxication alone would explain. If psychotic symptoms persist for more than a month after the person stops using, clinicians consider whether a separate condition like schizophrenia may be present.
Physical Health Consequences
Meth takes a visible toll on the body. One of the most recognizable effects is severe dental decay, widely known as “meth mouth.” The drug constricts blood vessels supplying the salivary glands, leading to chronic dry mouth. Without enough saliva to neutralize acids produced by oral bacteria, tooth enamel erodes rapidly. This process is made worse by behaviors common during a meth high: intense cravings for sugary drinks, compulsive teeth grinding (bruxism), and neglecting brushing or flossing. The combination can progress from cavities to painful gum inflammation to complete tooth loss.
Beyond dental problems, chronic use is associated with significant weight loss, skin sores (often from compulsive picking), weakened immune function, and cardiovascular damage including irregular heartbeat and increased risk of stroke. People who inject meth face additional risks from shared needles, including hepatitis and HIV.
How Widespread Meth Use Is
Methamphetamine remains a major public health problem in the United States. In 2024, an estimated 562,919 emergency department visits involved methamphetamine, accounting for 6.7% of all drug-related ER visits nationwide, at a rate of 166 per 100,000 people. More than half of those visits (57.8%) involved adults between 26 and 44 years old. The problem is not evenly distributed geographically: over half of meth-related ER visits occurred in the western United States, where the rate (373 per 100,000) was more than four times higher than in other regions. Men visited at nearly twice the rate of women.
Polysubstance use is also a growing concern. Nearly half (49.5%) of meth-related emergency visits in 2024 involved at least one other substance, with alcohol, cannabis, and cocaine being the most common combinations. Mixing meth with other drugs, particularly opioids like fentanyl, has contributed to rising overdose deaths in recent years.
Withdrawal and Recovery
Quitting meth after regular use triggers a withdrawal period that typically unfolds in two phases. The first, often called the crash, begins within hours of the last dose and can last several days. It is marked by extreme exhaustion, increased sleep, depression, and powerful cravings. The second phase is a longer stretch of low energy, difficulty feeling pleasure, irritability, and trouble concentrating that can persist for weeks or even months. This prolonged withdrawal happens because the brain’s dopamine system has been depleted and damaged, and rebuilding normal function takes time.
There are currently no FDA-approved medications specifically for methamphetamine addiction. Treatment typically relies on behavioral approaches, with contingency management (earning small rewards for staying drug-free) showing the strongest evidence of effectiveness. Cognitive behavioral therapy is also commonly used to help people identify triggers and build coping skills. Recovery rates improve significantly with longer treatment duration and ongoing support, but relapse is common, particularly in the first year.